Andrew Hughes
Director/Board Member at CellCentric Ltd.
Andrew Hughes active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Manchester Cancer Research Centre | Corporate Officer/Principal | - | - |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 06/04/2022 | - |
Career history of Andrew Hughes
Former positions of Andrew Hughes
| Companies | Position | Start | End |
|---|---|---|---|
| PCI BIOTECH HOLDING ASA | Director/Board Member | 01/05/2018 | 25/05/2023 |
| Independent Dir/Board Member | 01/05/2018 | 25/05/2023 | |
| The University of Manchester | Corporate Officer/Principal | 01/01/2006 | - |
| AstraZeneca AS | Corporate Officer/Principal | - | - |
Statistics
International
| Norway | 3 |
| United Kingdom | 3 |
| Israel | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PCI BIOTECH HOLDING ASA | Health Technology |
| Private companies | 3 |
|---|---|
| AstraZeneca AS | |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Manchester Cancer Research Centre |
- Stock Market
- Insiders
- Andrew Hughes
- Experience
